Skip to content

Stereotaxis STXS EV / sales

EV / sales at other companies

Abbott logo
AbbottABT
4.6×-1.0×
Boston Scientific logo
Boston ScientificBSX
-1.5×
Medtronic logo
MedtronicMDT
3.6×-0.4×
Stryker logo
StrykerSYK
5.4×-1.3×
ITG
Integer HoldingsITGR
2.4×-0.8×
Merit Medical Systems logo
Merit Medical SystemsMMSI
2.9×-1.9×

Other financials

Income statement

See full
Revenue$6.3M-15.8%
Gross profit$3.8M-6.6%
Operating income-$6.0M-0.9%
Net income-$5.9M-0.7%
EPS (diluted)-$0.06+14.3%

Balance sheet

See full
Cash & equivalents$14.6M+36.7%
Total debt$5.3M-10.0%
Total equity$14.4M+399%
Total assets$54.0M+18.2%

Cash flow

See full
Operating cash flow-$3.4M-93.5%
CapEx$79.0K
Free cash flow-$3.5M

Valuation

See full
Market cap$168.11M-11.6%
Enterprise value$158.77M-15.9%
P/S5.4×-0.6×

Profitability

See full
Gross margin53.9%+0.5pp
Operating margin-71%-14.0pp
Net margin-69.5%-13.7pp
FCF margin-35.5%-2.4pp

Returns & leverage

See full
Return on equity-251.5%-29.9pp
Debt / equity0.4×-1.7×
Current ratio1.6×+0.5×

Where this comes from

Calculated from Stereotaxis’s reported figures.

Based on the most recent quarter.

The official record: Stereotaxis’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stereotaxis's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stereotaxis's EV / sales?
Stereotaxis (STXS) reported EV / sales of 5.4× in Q1 2026.
How has Stereotaxis's EV / sales changed year-over-year?
Stereotaxis's EV / sales increased by 2.1% year-over-year, from 5.3× to 5.4×.
What is the long-term trend for Stereotaxis's EV / sales?
Over 5 years (2020 to 2025), Stereotaxis's EV / sales has grown at a -13.0% compound annual growth rate (CAGR), from 12.8× to 6.4×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.